INDEX TO POSTGRADUATE VOLUME 89 MEDICINE JANUARY-JUNE 1991 SUBJECTS ABDOMEN ALLERGY BURNS ¢ Pulmonary artery catheterization ¢ Pain in celiac axis syndrome, ¢ Allergic cutaneous reactions, ¢ Smoke inhalation injuries, a for bedside assessment of hemo- causes, diagnostic techniques, identification and treatment. 89(8): perbaric oxygen therapy. (VP) dynamic state, when to use, how and surgical intervention. 89(1):239 75° 89(1):221 to perform, and what complica- ACCIDENTS ¢ Treatment with second-genera- tions to expect. 89(2):169* © Preventing pool drownings with tion antihistamines, decreased in- CANCER: See Neoplasms e Pulmonary embolism, newer a safety cover. (ED) 89(8):19 cidence of side effects. 89(6):87* CARDIOVASCULAR concepts in diagnosis, manage- ACNE ALZHEIMER’S DISEASE ¢ Aortic pseudoaneurysm, post- ment, and prophylaxis. 89(8):195* ¢ Treatment guidelines. 89(8):40° * Clues to its cause. 89(4):231* traumatic, review of radiographic e Raynaud's ot diagnosis ACQUIRED IMMUNODEFICIENCY ANEMIA findings. 89(6):173* and treatment. 89(4):17 SYNDROME (AIDS) * Determining cause using a sys- e Aortic stenosis, degenerative, e Valvular heart cane use of Exposure by healthcare work- tematic, cost-effective approach. effect of aging population, treat- echocardiography in diagnosis ers, risk of HIV infection, policy 89(6):161* ment options available. 89(2):143* and management. 89(6):123* recommendations. 89(3):30° ¢ Normocytic and macrocytic, © Congestive heart failure. (PN) ¢ Vascular headache followed by ¢ Human immunodeficiency virus stepwise, cost-effective approach 89(6):212, 215 neurologic deficits, report of case in women, latest information on di- to diagnosis. 89(8):125* * Congestive heart failure, pro- in young woman. (CR) 89(7):87 nosis, therapy, and prevention. e Three-step approach to evalua- a stepwise drug treatment. ¢ Venous thrombosis, acute, diag- [2):135 tion. 89(2):179* 9(6):102* nostic methods and treatment rec- * Reducing adolescent risk of HIV ANESTHESIA © Congestive heart failure, severe, ommendations, preventing recur- transmission, how physicians can ¢ Local, alternative procedures success of drug therapy and rence. 89(7):73* help teenagers. 89(3):49* and agents for wy pain of in- overview of success of cardiac CATHETERIZATION ¢ Screening policies for travelers So anesthesia. 89(3):71* transplantation. 89(6):111* © Cardiac, in assessment of aortic to Eastern Europe. 89(4):146 ANKLE © Coronary artery disease, nonin- stenosis. 89(2):146 Pe- ¢ Sprains, diagnosis and treat- vasive detection methods. 89(5): ¢ Pulmonary artery, when to use, diatrics ment, rehabilitation. 89(1):251 149° how to perform, and what compli- AGING ANTIBIOTICS: See Drugs, antibiotic ¢ Extracranial atherosclerosis and cations to expect. 89(2):169* e Alzheimer’s disease, clues to the APPETITE DISORDERS cerebrovascular disease, minimiz- CHOLESTEROL cause. 89(4):231* e Anorexia or bulimia, under- ing risk of stroke by thorough eval- ¢ Dietary and pharmacologic ive aortic stenosis, ef- standing their development and in- uation and management. 89(4): methods to reduce serum lipid lev- fect of graying of America, over- terrupting the patterns. 89(4):209* 193* els. 89(1):81* view and available treatment op- ARTHRITIS: See Rheumatic dis- © Hypertension. (PN) 89(8):278 © High blood levels, excessive use tions. 89(2):143* eases © Hypertension, advantages of of vitamin B (niacin) is harmful and ¢ Effects of antihypertensive ASTHMA treatment with alpha, blockers, unneccessary. (CT) 89(4):262 agents in middle-aged and elderly e Effects on and of pregnancy. particular benefits for middle-aged e Reduced lipid levels, added patients. 89(8):104, 106 89(1):125* and elderly patients. 89(8):89* benefit of apha, blocker hyperten- © Falls in elderly, procedures to © Hypertension, effect of nonpre- sion treatment. 89(8):97 determine cause, approach to pre- BEHAVIORAL MEDICINE scription drugs. 89(6):195* CONNECTIVE TISSUE vention. 89(1):139" © Biofeedback in treatment of © Hypertension, overview of three ¢ Current diagnostic criteria and © Pain in per stepwise pre- Raynaud's syndrome. 89(4):179 newer antihypertensive agents. role of serologic tests. 89(4):253* scription of an — and adju- BEREAVEMENT 89(5):75* COST-BENEFIT ANALYSIS vant agents for relief. 89(4):217* ¢ After miscarriage, need for e Hypertension, renovascular, dif- ¢ Oregon’s healthcare rationing alps: See Acquired immunodefi- physician to recognize patient’s ficulties in diagnosis and treat- list. (ED) 89(7):15 ciency syndrome (AIDS) emotional 20 - ell as physical ment. 89(5):93* AIRWAY OBSTRUCTION ¢ Hypertensive emergencies, DEATH/DYING * Bronchial asthma, effects on ¢ Helping aman understand ~ for successful control. 89(5): * Abiding by living wills. (MEM) and of pregnancy. 89(1):125* and conquer grief. 89(8):1 1* 89(5):39 ¢ Heimlich maneuver for choking. BLEEDINGS:e e Hemorrhage * Ischemic heart disease, assess- ¢ Active versus passive euthana- (PN) 89(3):100, 103 BLOOD GLUCOSE ment and value of risk factor re- sia. (PH) 89(3):21 ALCOHOLISM © Self-monitoring with portable duction to prognosis. 89(1):44* ¢ Helping patients understand Aids to identifying alcoholic pa- meters. 89(4):75* ¢ Mesenteric vascular diseases as and conque—r — 89(8):117* tients, overview of treatment prin- BRAIN cause of celiac axis syndrome, di- DELIVERYOF HEALTHCARE ciples, and tips = gpl the e Abscesses, site of anaeropic in- agnostic techniques and surgical © Medical care in Peru, stark dif- problem in elderly.8 : fection, diagnosis and treatment. intervention. 89(1):239 ferences. (MEM) 89(8):249 * Cause of severe te 89(8):221 ¢ Myocardial, cerebrovascular, ¢ Oregon’s healthcare rationing penia, treatment and prognosis. ¢ Neuroleptic malignant syn- and peripheral vascular symp- list. (ED) 89(7):15 (CR) 89(6):75 drome, recognition and treatment. toms, serum lipid-lowering thera- 89(5):175* py. 89(1):81* e After acute myocardial infarc- BREAST DISEASES © Nitrate therapy, indications for tion, risk factors and psychological “Major clinical discussion e Cancer, early diagnosis through use, how to prescribe to avoid de- intervention. 89(3):83* universal screening. 89(3):55* velopment of tolerance to its ef- ¢ Component of chronic fatigue CT, Cues/Tips * Mastectomy followed by breast fects. 89(1):67* syndrome. 89(2):44 ED, Editorial reconstruction, today’s options. ¢ Peripheral vascular disease, © Differentiation from normal grief, MEM, Memories Worth Sharing 89(8):205* cause of lower limb problems in an approach to counseling and PH, Physician-at-Large ¢ Nipple discharge in women, diabetic patients. 89(8):239 support. 89(8):117* PN, Patient Notes three types, diagnosis and treat- ¢ Post-myocardial-infarction de- VP, Viewpoint ment. 89(3):65* pression, risk factors and psycho- ¢ Contact, allergic, identification logical intervention. 89(3):83* and treatment. 89(8):75* VOL 89/NO 8/JUNE 1991/POSTGRADUATE MEDICINE INDEX TO POSTGRADUATE VOLUME 89 MEDICINE JANUARY-JUNE 1991 SUBJECTS ABDOMEN ALLERGY BURNS ¢ Pulmonary artery catheterization ¢ Pain in celiac axis syndrome, ¢ Allergic cutaneous reactions, ¢ Smoke inhalation injuries, a for bedside assessment of hemo- causes, diagnostic techniques, identification and treatment. 89(8): perbaric oxygen therapy. (VP) dynamic state, when to use, how and surgical intervention. 89(1):239 75° 89(1):221 to perform, and what complica- ACCIDENTS ¢ Treatment with second-genera- tions to expect. 89(2):169* © Preventing pool drownings with tion antihistamines, decreased in- CANCER: See Neoplasms e Pulmonary embolism, newer a safety cover. (ED) 89(8):19 cidence of side effects. 89(6):87* CARDIOVASCULAR concepts in diagnosis, manage- ACNE ALZHEIMER’S DISEASE ¢ Aortic pseudoaneurysm, post- ment, and prophylaxis. 89(8):195* ¢ Treatment guidelines. 89(8):40° * Clues to its cause. 89(4):231* traumatic, review of radiographic e Raynaud's ot diagnosis ACQUIRED IMMUNODEFICIENCY ANEMIA findings. 89(6):173* and treatment. 89(4):17 SYNDROME (AIDS) * Determining cause using a sys- e Aortic stenosis, degenerative, e Valvular heart cane use of Exposure by healthcare work- tematic, cost-effective approach. effect of aging population, treat- echocardiography in diagnosis ers, risk of HIV infection, policy 89(6):161* ment options available. 89(2):143* and management. 89(6):123* recommendations. 89(3):30° ¢ Normocytic and macrocytic, © Congestive heart failure. (PN) ¢ Vascular headache followed by ¢ Human immunodeficiency virus stepwise, cost-effective approach 89(6):212, 215 neurologic deficits, report of case in women, latest information on di- to diagnosis. 89(8):125* * Congestive heart failure, pro- in young woman. (CR) 89(7):87 nosis, therapy, and prevention. e Three-step approach to evalua- a stepwise drug treatment. ¢ Venous thrombosis, acute, diag- [2):135 tion. 89(2):179* 9(6):102* nostic methods and treatment rec- * Reducing adolescent risk of HIV ANESTHESIA © Congestive heart failure, severe, ommendations, preventing recur- transmission, how physicians can ¢ Local, alternative procedures success of drug therapy and rence. 89(7):73* help teenagers. 89(3):49* and agents for wy pain of in- overview of success of cardiac CATHETERIZATION ¢ Screening policies for travelers So anesthesia. 89(3):71* transplantation. 89(6):111* © Cardiac, in assessment of aortic to Eastern Europe. 89(4):146 ANKLE © Coronary artery disease, nonin- stenosis. 89(2):146 Pe- ¢ Sprains, diagnosis and treat- vasive detection methods. 89(5): ¢ Pulmonary artery, when to use, diatrics ment, rehabilitation. 89(1):251 149° how to perform, and what compli- AGING ANTIBIOTICS: See Drugs, antibiotic ¢ Extracranial atherosclerosis and cations to expect. 89(2):169* e Alzheimer’s disease, clues to the APPETITE DISORDERS cerebrovascular disease, minimiz- CHOLESTEROL cause. 89(4):231* e Anorexia or bulimia, under- ing risk of stroke by thorough eval- ¢ Dietary and pharmacologic ive aortic stenosis, ef- standing their development and in- uation and management. 89(4): methods to reduce serum lipid lev- fect of graying of America, over- terrupting the patterns. 89(4):209* 193* els. 89(1):81* view and available treatment op- ARTHRITIS: See Rheumatic dis- © Hypertension. (PN) 89(8):278 © High blood levels, excessive use tions. 89(2):143* eases © Hypertension, advantages of of vitamin B (niacin) is harmful and ¢ Effects of antihypertensive ASTHMA treatment with alpha, blockers, unneccessary. (CT) 89(4):262 agents in middle-aged and elderly e Effects on and of pregnancy. particular benefits for middle-aged e Reduced lipid levels, added patients. 89(8):104, 106 89(1):125* and elderly patients. 89(8):89* benefit of apha, blocker hyperten- © Falls in elderly, procedures to © Hypertension, effect of nonpre- sion treatment. 89(8):97 determine cause, approach to pre- BEHAVIORAL MEDICINE scription drugs. 89(6):195* CONNECTIVE TISSUE vention. 89(1):139" © Biofeedback in treatment of © Hypertension, overview of three ¢ Current diagnostic criteria and © Pain in per stepwise pre- Raynaud's syndrome. 89(4):179 newer antihypertensive agents. role of serologic tests. 89(4):253* scription of an — and adju- BEREAVEMENT 89(5):75* COST-BENEFIT ANALYSIS vant agents for relief. 89(4):217* ¢ After miscarriage, need for e Hypertension, renovascular, dif- ¢ Oregon’s healthcare rationing alps: See Acquired immunodefi- physician to recognize patient’s ficulties in diagnosis and treat- list. (ED) 89(7):15 ciency syndrome (AIDS) emotional 20 - ell as physical ment. 89(5):93* AIRWAY OBSTRUCTION ¢ Hypertensive emergencies, DEATH/DYING * Bronchial asthma, effects on ¢ Helping aman understand ~ for successful control. 89(5): * Abiding by living wills. (MEM) and of pregnancy. 89(1):125* and conquer grief. 89(8):1 1* 89(5):39 ¢ Heimlich maneuver for choking. BLEEDINGS:e e Hemorrhage * Ischemic heart disease, assess- ¢ Active versus passive euthana- (PN) 89(3):100, 103 BLOOD GLUCOSE ment and value of risk factor re- sia. (PH) 89(3):21 ALCOHOLISM © Self-monitoring with portable duction to prognosis. 89(1):44* ¢ Helping patients understand Aids to identifying alcoholic pa- meters. 89(4):75* ¢ Mesenteric vascular diseases as and conque—r — 89(8):117* tients, overview of treatment prin- BRAIN cause of celiac axis syndrome, di- DELIVERYOF HEALTHCARE ciples, and tips = gpl the e Abscesses, site of anaeropic in- agnostic techniques and surgical © Medical care in Peru, stark dif- problem in elderly.8 : fection, diagnosis and treatment. intervention. 89(1):239 ferences. (MEM) 89(8):249 * Cause of severe te 89(8):221 ¢ Myocardial, cerebrovascular, ¢ Oregon’s healthcare rationing penia, treatment and prognosis. ¢ Neuroleptic malignant syn- and peripheral vascular symp- list. (ED) 89(7):15 (CR) 89(6):75 drome, recognition and treatment. toms, serum lipid-lowering thera- 89(5):175* py. 89(1):81* e After acute myocardial infarc- BREAST DISEASES © Nitrate therapy, indications for tion, risk factors and psychological “Major clinical discussion e Cancer, early diagnosis through use, how to prescribe to avoid de- intervention. 89(3):83* universal screening. 89(3):55* velopment of tolerance to its ef- ¢ Component of chronic fatigue CT, Cues/Tips * Mastectomy followed by breast fects. 89(1):67* syndrome. 89(2):44 ED, Editorial reconstruction, today’s options. ¢ Peripheral vascular disease, © Differentiation from normal grief, MEM, Memories Worth Sharing 89(8):205* cause of lower limb problems in an approach to counseling and PH, Physician-at-Large ¢ Nipple discharge in women, diabetic patients. 89(8):239 support. 89(8):117* PN, Patient Notes three types, diagnosis and treat- ¢ Post-myocardial-infarction de- VP, Viewpoint ment. 89(3):65* pression, risk factors and psycho- ¢ Contact, allergic, identification logical intervention. 89(3):83* and treatment. 89(8):75* VOL 89/NO 8/JUNE 1991/POSTGRADUATE MEDICINE DIABETES their effects—good and bad. 89(2): e For bacterial skin infections in DRUGS, CALCIUM ANTAGONIST ¢ Amyotrophy, report of case in 195* children. 89(4):111 ¢ For hypertensive emergencies. which patient had no pain and re- DRUG ADMINISTRATION ¢ For coexisting chlamydial and 89(5):115 covered rong |a fter con- ¢ Gastrointestinal therapeutic sys- gonococcal infections in men and DRUGS, CARDIAC GLYCOSIDE servative treatment. (CR) 89(3):90 tem (GITS) for delivery of antihy- women. 89(7):59 * Digoxin for progressive conges- ¢ Complicated by lower limb pertensives. 89(5):84 ¢ Penicillin G for syphilis, recom- tive heart failure. 89(6):104 problems, causes, prevention, and * Spheroidal oral drug absorption mended treatment regimens for DRUGS, CATECHOLAMINE ACTIVA- treatment. 89(8):237* system (SODAS) for delivery of an- various stages of disease. 89(1):200 TOR ¢ Current research strategies that tihypertensives. 89(5):81 DRUGS, ¢ Dextroamphetamine sulfate for may soon become therapeutic op- DRUG TESTING ¢ Scopolamine for ~ _— of prophylaxis of motion sickness. tions. 89(6):45* ¢ In athletes, substances used to motion sickness. 89(6):140 89(6):142 ¢ Neuropathic arthropathy, or increase muscle mass and energy DRUGS, ANTICOAGULANT Charcot’s disease, diagnostic ap- and their effects. 89(2):195* ¢ For acute venous thrombosis. e For bronchial asthma, use in proach. 89(4):163* DRUG THERAPY 89(7):73 pregnancy. 89(1):130 ¢ Premixed insulins, comparisons ¢ Alpha, blockers for safe and ef- ¢ Heparin therapy for acute pul- DRUGS, DISEASE-MODIFYING AN- with other insulin preparations. fective hypertension treatment. monary embolism. 89(8):197 TIRHEUMATIC 89(4):52* 89(8):89* * Warfarin regimens for pulmonary © Guide to available treatments for ¢ Presenting symptoms include ¢ Combination sulfonylureas and embolism. 89(8):198 rheumatoid arthritis and their use. unilateral headache with eye pain. insulin in type Il diabetes treat- 89(2):75* (CR) 89(8):161 ment. 89(4):68 ¢ Indications for after febrile con- DRUGS, © Self-monitoring blood glucose, ¢ Disease-modifying antirneumat- vulsion. 89(5):221 ¢ Stepwise regimen for treatment device-related concerns, user con- ic drugs for rheumatoid arthritis, of progressive congestive heart cerns. 89(4):75* guide to their use. 89(2):81 © For bulimia. 89(4):215 failure. 89(6):104 © Sliding-scale insulin therapy, © For peptic ulcer disease, current © For depression, what to consid- DRUGS, DOPAMINERGIC proposed benefits and potential management ideas and future er before prescribing for post-myo- ¢ Withdrawal of antiparkinson problems. 89(5):46* prospects. 89(4):91* -*t rtelaeacaae patients. 89(3): therapy cause of neuroleptic ma- © Type Il, intensive management, * In chronic fatigue syndrome, in- a syndrome, management. attaining treatment goals without dications. 89(2):53 DRUGS, ANTIHISTAMINE 89(5):177 exacerbating coexisting disorders. * Medications for bed-wetting in ¢ For prophylaxis and/or treat- DRUGS, ANTAGONIST 89(4):65* children. 89(2):69 ment of motion sickness. 89(6):141 e In peptic ulcer disease treat- DIAGNOSTIC TECHNIQUES ¢ Nitrate therapy, when to use and © Second-generation, their phar- ment. 89(4):91 © For deep vein thrombosis. 89(7): how to prescribe to avoid develop- macology and practical ideas for 74 ment of tolerance to its effects. clinical use. 89(6):87* ¢ Improved survival rates after © For definitive diagnosis of pul- 89(1):67* DRUGS, ANTIHYPERLIPIDEMIC cardiac transplantation. 89(6):114 monary embolism. 89(8):195 ADVERSE REACTIONS ¢ Serum lipid-lowering therapy for ¢ For evaluation of heartburn. e Agranulocytosis from antiar- high-priority patients with myocar- ¢ Effect on blood pressure con- 89(7):48 — agents, treatment. 89(1): dial, cerebrovascular, and periph- trol. 89(6):195* © For normocytic and macrocytic 181* eral vascular symptoms of coro- DRUGS, NONSTEROIDAL ANTI- anemias. 89(8):125* ¢ Cutaneous, clinical manifesta- nary artery disease. 89(1):81* INFLAMMATORY ¢ For renovascular hypertension. tions and treatment. 89(8):75 ANTIHYPERTENSIVE © Cause of upper gastrointestinal 89(5):102 ¢ Drug fever, ——<, ¢ Alpha, blockers, advantages in ulcer disease. 89(7):33* e Laboratory assays relevant to and treatment. 89(5):16 treatment of hypertension, particu- ¢ For ames thrombophlebitis. diagnosis of rheumatic diseases. DRUGS, ANALGESIC lar benefits for middle-aged and 89(7):73 89(2):93* © For pain in the elderly, tips for elderly patients. 89(8):89* DRUGS, RESPIRATORY INHALANT ¢ Magnetic resonance imaging in stepwise prescription. 89(4):217* © Clonidine hydrochloride for hy- * Cromolyn sodium for bronchial diagnosis of multiple sclerosis. ¢ Narcotic, special considerations pertensive emergencies. 89(5):113 asthma, use in pregnancy. 89(1): 89(8):187* for use in the elderly. 89(4):221 ¢ Three newer agents, overview. ¢ Thallium imaging to detect coro- DRUGS, ANESTHETIC 89(5):75* DRUGS, SALICYLATE nary artery disease. 89(5):149 e Alternative agents for local ¢ Poisoning from enteric-coated ¢ Western blot testing to establish anesthesia to reduce pain and e Guidelines for use in gouty aspirin, delayed absorption may diagnosis of human immunodefi- anxiety of induction. 89(3):71* arthritis. 89(2):111* complicate management. (CR) ciency virus. 89(3):39* DRUGS, ANGIOTENSIN-CONVERT- DRUGS, ANTINEOPLASTIC 89(5):61 DIARRHEA ING ENZYME INHIBITOR e Reactions may include malar DRUGS, SIDE EFFECTS ¢ Traveler’s, prophylactic treat- ¢ For severe congestive heart fail- flushes and facial rashes. 89(1): e Abnormal vaginal bleeding ment. 89(8):153 ure. 89(6):111 caused by certain medications. DIET: See Nutrition DRUGS, ANTIARRHYTHMIC DRUGS, ANTIVIRAL 89(1):207 DROWNING * Cause of agranulocytosis, antic- ¢ Zidovudine therapy after expo- e Anemia caused ty specific e Using a pool safety cover to — and treating reaction. 89(1): sure to human immunodeficiency drugs. 89(6):163 prevent accidents. (ED) 89(8):19 1° virus. 89(3):34 ¢ From antihistamines, decreased DRUG ABUSE DRUGS, ANTIBIOTIC or eliminated with newer second- ¢ “Designer drugs,” description of ¢ Fluoroquinolones, clinical indi- * Sympathomimetic, use in preg- generation agents. 89(6):87* common ones and their effects, cations and contraindications and nancy. 89(1):128 © From nitrate therapy. 89(1):75 identification and treatment of in- drug interactions. 89(1):101* ¢ Theophylline for bronchial asth- © Neuroleptic malignant syndrome, toxication. 89(6):67* ¢ For anaerobic infections, empiri- ma, effects in pregnant women. caused by neuroleptic therapy, ¢ Substances used by athletes to cal selection of proven agents. 89(1):127 recognition and treatment. 89(5): increase muscle mass and energy, 89(8):229 continued VOL 89/NO 8/JUNE 1991/POSTGRADUATE MEDICINE TO VOLUME 89 CONTINUED * Peptic ulcer disease caused by ‘AL HAZARDS ¢ Gallstone pancreatitis, choosing HEMORRHOIDS use of nonsteroidal anti-inflamma- ¢ In Eastern Europe, considera- and timing treatment, with repre- ¢ Internal and external, treatment tory drugs. 89(7):33* tions for travel. 89(4):145 sentative case reports. 89(2):123* choices. 89(1):149* DRUGS, SULFONYLUREA ENZYMES * Gastroesophageal reflux dis- HEPATITIS ¢ For treatment of type |! dia- ¢ Liver, abnormal levels, evalua- ease, Causes, typical clinical pre- e Virai, sexually transmitted to betes. 89(4):67 tion and significance in asymp- sentations, diagnosis, and treat- women, diagnosis and therapy. DRUGS, VASODILATOR tomatic patients. 89(4):137* ment. 89(7):45* 89(2):139 * Diazoxide for hypertensive EQUIPMENT ¢ Malabsorption, symptoms of HORMONES emergencies. 89(5):114 ¢ Portable blood glucose meters, lactose intolerance, avoidance. e Estrogenic excess in males lead- ¢ For severe congestive heart fail- teaching patients how to correctly 89(8):175* ing to gynecomastia. (CR) 89(2): ure. 89(6):112 monitor diabetes. 89(4):75* ¢ Ogilvie’s syndrome, apn 191 ¢ Hydralazine hydrochloride for ETHICS, MEDICAL and management. 89(5):131* : See Cardiovascu- hypertensive emergencies. 89(5): *° 'Plagiaram iinn medical publish- ¢ Pancreatic pseudocysts, opera- lar diseases 115 po (ED) 8t9(4e): 1 tive and nonoperative treatment o© thNeirt ractaer ditahce rappryo blfoerm sa,n giwnhae n antdo y. or versus passive, one —199_° —— and success rates. 89(4): I¢ MMRUeNcIoZmAmTeInOdNa tions for interna- use and how to prescribe to avoid physician's point of view. (PH) ¢ Peptic ulcer disease, associa- tional travel. 89(8):147 of tolerance to its ef- 89(3):21 tion with use of nonsteroidal anti- e Recommendations for travel to fects. 89(1):75* EXERCISE inflammatory drugs. 89(7):33* Eastern Europe. 89(4):144 © Nitroglycerin for ew ¢ Component of type Ii diabetes ¢ Peptic ulcer disease, current IMMUNOLOGIC — 89(5):113 treatment. 89(4):66 management techniques, future ¢ Chronic fatigue syndrome, eval- Nitroprusside sodium for hyper- EXERCISE TESTING prospects. 89(4):91* uation—including possible organic connie emergencies. 89(5):113 ¢ In identifying myocardial isch- GENITAL DISEASES and psychiatric factors— review of © Stepwise regimen for omens emia due to coronary artery dis- ¢ Chlamydial and gonococcal in- controversy — Pa and of progressive congestive heart ease. 89(5):149 fections, need for simultaneous management.8 : failure. 89(6):104 EYE DISORDERS treatment to avoid serious compli- DYSPHAGIA e Injuries, causes and prevention. cations. 89(7):56* ¢ For pregnant patients with bron- *® Neurogenic oropharyngeal, eval- 89(5):121°* e Chiamydial infections. (PN) chial asthma. 89(1):127 uation and management. 89(5):203* * Ophthalmoplegia with head- 89(7): 94, 97 INCONTINENCE ache, presenting symptom in this ¢ Potential cause of dyspareunia. ¢ Bed-wetting child, current man- ECHOCARDIOGRAPHY case of diabetes. (CR) 89(8):161 89(5):67 agement options. 89(2):63* * Role in diagnosis of ~> ne GERIATRICS: See Aging tive aortic stenosis. 89(2):145 FACE GRIEF: See Bereavement ¢ Anaerobic, clinical clues, empiri- e Use in diagnosis and manage- e Butterfly rash and malar flush, e After miscarriage, need for cal treatment with proven antibi- ment of patients with valvular heart ten disorders as possible causes, physician to recognize patients’ otics. 89(8):221* disease. 89(6):123* clinical characteristics. 89(1):225* emotional as well as physical e Antibacterial spectrum of fluoro- EDUCATION, FALLS needs. 89(2):207* quinolones, clinical indications and ¢ Focusing on outcomes, not in- ¢ In elderly, procedures to deter- GYNECOLOGY: See Obstetrics/Gy- contraindications. 89(1):101* comes. (PH) 89(8):33 mine cause, approach to preven- necology © Chlamydial. (PN) 89(7):94, 97 © Skills acquired in human behav- tion. 89(1):139* ¢ Chlamydial, coexisting with gon- ior class among most useful. (PH) FEVER HEADACHE orrhea, detection and treatment. 89(7):27 ¢ Drug-induced, causes, diagno- * Migraine stroke. (CR) 89(7):89 89(7):56" ELDERLY: See Aging sis, and treatment. 89(5):167* e Vascular, followed by neurologic ¢ Foot ulcers in diabetic patients, EMERGENCY MEDICINE © Febrile convulsions, current rec- deficits, report of case in young diagnosis and treatment. 89(8):239 * Heimlich maneuver for choking. ommendations for management. woman. (CR) 89(7):87 ¢ Herpes simplex virus, sexually (PN) 89(3):100, 103 89(5):217" HEART DISEASE: See Cardiovas- transmitted viral disease, current ¢ Hypertensive emergencies, FOOT cular diseases information on diagnosis, treat- steps for successful control. ¢ Identification and management HEMATOLOGIC DISEASES ment, and prevention. 89(2):133 89(5):111* of most common problems in e Agranulocytosis from antiar- ¢ Human immunodeficiency virus, ¢ Resuscitation in children, role of adults. 89(5):183* rhythmic agents, anticipating and establishing diagnosis using West- intraosseous infusion. 89(4):129* FRACTURES treating such a reaction. 89(1):181* ern biot test. 89(3):39* ¢ Resuscitation, initial steps for © Stress in athletes, increasing in- e Anemia, systematic, cost-effec- ¢ Human immunodeficiency virus success, with a helpful mnemonic. cidence, recognition and recom- tive approach to determining in healthcare workers, what is risk, 89(1):117* mendations for treatment. 89(6): cause. 89(6):161* what to do before and after expo- ¢ Techniques to arrest variceal e Anemia, three-step approach to sure. 89(3):30* bleeding. 89(6):147 evaluation based on categorizing ¢ Human immunodeficiency virus, e US Navy's high-tech facilities GALLBLADDER DISEASES type, establishing presence or ab- reducing adolescent risk, how and well-trained personnel on © Gallstone pancreatitis, choosing sence of pancytopenia, and using physicians can help teenagers. os hospital ships. (ED) 89(6): and timing treatment, with repre- reticulocyte count. 89(2):179* 89(3):49* sentative case reports. 89(2):123* ¢ Normocytic and macrocytic ¢ Malaria, prophylaxis recommen- ENDOCRINE DISORDERS GASTROINTESTINAL DISEASES anemias, stepwise, cost-effective dations for international travelers. * Diabetes: See Diabetes ¢ Abnormal liver enzyme levels, approach to diagnosis. 89(8):125* 89(8):150 ¢ Gynt eocfo mcaasstei ar,e latceadu satlo cfiarcrthoorssi,s eavsaylmupattoimoant ica npda tisenitgsn.i f8i9c(a4)n:c1e3 7*i n a¢ lcTohhrool mbuosce,y totpreeantimae nts ecaonndd arpyro gt-o e{e (PN) 89(5):248, of liver. (CR) 89(2):191 ¢ Bleeding, esophageal and gas- nosis. (CR) 89(6):75 © Skin, in children, examples with ¢ Hypothyroidism, juvenile, tric endoscopy in critically ill pa- HEMORRHAGE appropriate treatments. 89(4):109* growth and development abnor- tients, determining cause of bleed- ¢ Bleeding, esophageal and gas- ¢ Syphilis, recent upswing in oc- malities. (CR) 89(2):59 ing and therapeutic options. tric endoscopy in critically ill pa- currence, diagnosis and treatment. ENDOSCOPY 89(4):123* tients, determining cause of bieed- 89(1):193* ¢ Endoscopic sphincterotomy, * Bleeding esophagogastric var- ing and therapeutic options. INFE CTIOUS MONONUCLEOSIS role in treatment of galistone pan- ices, emergency treatment meth- 89(4):123* e Patient information. (PN) 89(5): creatitis. 89(2):124 ods, prevention of recurrent bieed- ¢ Bleeding esophagogastric vari- 248, 251 © Of upper gastrointestinal tract in ing. 89(6):147* ces, emergency treatment meth- INJURIES: See Trauma critically ill patients, determining © Celiac axis syndrome, causes, ods, prevention of recurrent bleed- INSULIN course of bleeding and therapeutic diagnostic techniques, and surgi- ing. 89(6):147* ¢ Delivery methods for control of options. 89(4):123* cal intervention. 89(1):239* ¢ Hematoma, vulvar, from trau- glycemia. 89(6):46 ENTERAL FEEDING * Chilaiditi’s syndrome, report of matic injury, evaluation and appro- e For controlling blood glucose ¢ In critically ill, guidelines. 89(5): case. (CR) 89(4):249 priate treatment. 89(4):115* levels in type Il diabetes. 89(4):67 193 VOL 89/NO 8&/JUNE 1991/POSTGRADUATE MEDICINE e Premixed, comparisons with LUNG DISEASES ¢ Rheumatic diseases, laboratory ¢ Dietary methods to reduce other insulin preparations, benefits ¢ Cancer, small-cell and non- investigation. 89(2):93* serum lipid levels in high-priority and drawbacks. 89(4):52* small-cell, establishing diagnosis ¢ Rheumatoid arthritis. 89(2):228, patients with coronary artery dis- © Sliding-scale therapy, proposed and determining appropriate treat- 231 ease. 89(1):81 benefits and potential problems ment. 89(4):101* ¢ Rheumatoid arthritis, new devel- e Lactose intolerance, diagnosis, ¢ Pulmonary embolism, newer opments in treatment, specifically ways to avoid symptoms of mal- INTESTINAL : See Gas- concepts in diagnosis, manage- disease-modifying antirheumatic absorption. 89(8):175" trointestinal diseases ment, and prophylaxis. 89(8):195* drugs. 89(2):75* ¢ Supplementation for improved IRON ¢ Stress fractures in athletes, respiratory function in ventilator- ¢ Deficiency, cause of anemia. MAMMOGRAPHY recognition and recommendations dependent patients. 89(1):177 89(6):167 © Role in screening for breast can- for modification of training regimen © Support of critically ill, guidelines cer. 89(3):55 and risk factors. 89(6):185* for optimal management. 89(5): JOINTS MARRIAGE ¢ Acute monarticular arthritis, ¢ Placing wife in dependent role, a NEOPLASMS ¢ Tube feeding versus spoon need for rapid diagnosis and treat- very good example. (MEM) ¢ Breast cancer, early diagnosis feeding in the comatose, thoughts ment. 89(7):79* 89(6):39 through universal screening. 89(3): on active versus passive euthana- MEDICAL 55* sia. (PH) 89(3):21 KIDNEY DISEASES ¢ Active versus passive euthana- ¢ Breast cancer, impact of delay e Renovascular hypertension, dif- sia. (PH) 89(3):21 in seeking care. 89(4):156 OBSTETRICS/GYNECOLOGY ficulties in diagnosis and manage- * Considering the concept of e Breast, cause of bloody nipple ¢ Amenorrhea, relationship to ment. 89(5):93* “greater good” and the “lesser discharge, diagnosis and treat- stress fractures in female athletes. ¢ Transplantation, counseling fam- bad” it may imply. (MEM) 89(1):155 ment. 89(3):66 89(6):186 ily members before donating a kid- ¢ Example of good clinical diag- © Cervical cancer, importance of ¢ Dyspareunia, tracing the cause. ney. 89(3):73* nosis. (MEM) 89(4):41 routine Pap smear screening in 89(5):67* © Office lab testing—why the Clin- treatment and prevention in all ¢ Miscarriage, differential diagno- LABORATORY INVESTIGATION ical Laboratory Improvement women. (PH) 89(1):27 sis and management, recognizing e Enzyme immunoassay and Amendments of 1988 (CLIA ’88) ¢ Cutaneous malignant melano- emotional as well as physical Western blot test to establish diag- proposed by the Health Care Fi- - diagnosis and treatment. 89(8): needs. 89(2):207* nosis of human immunodeficiency omeg | Administration won’t ¢ Nonobstetric vulvar hematomas, virus infection. 89(3):39* work. (ED) 89(1):15 ¢ Lung cancer, small-cell and non- evaluation and appropriate treat- —1 Raynaud’s syndrome. 89(4): w¢ itOhf ftihcee Helaalbtohr aCtaorrei esF—irneagnicsitnge riAndg- samnadl l-dceetlelr,m ineistnagb laipsphrionpgr idatiea gntorseaits- m¢ enPtr.e g8n9a(n4)c:y1,1 5*e ffects on asthma * Health Care Financing Adminis- ministration. (ED) 89(2):15 ment. 89(4):101* and vice versa with discussion of tration’s proposed regulations— © Power of intuition in physician’s ¢ Malignant melanoma, prevent- often necessary pharmacotherapy. the Clinical Laboratory Improve- diagnostic armamentarium. (PH) ing delay in seeking care. 89(4): 89(1):125* ment Amendments of 1988 (CLIA 89(6):25 156 ¢ Routine Pap smear screening *88)—why they won’t work. (ED) ¢ Proposed regulations cn office ¢ Pancreatic pseudocysts, opera- for all women. (PH) 89(1):27 89(1):15 laboratories from the Health Care tive and nonoperative treatment ¢ Vaginal bleeding, abnormal, di- ¢ In diagnosis of normocytic and Financing Administration—practic- methods and success rates. 89(4): agnostic techniques and therapeu- macrocytic anemias. 89(8):125* ing primary care physicians won't tic options. 89(1):205* ¢ In women with abnormal vaginai be included in rule making. (ED) ¢ Squamous cell and basal cell ORGAN DONORS bleeding. 89(1):213 89(3):13 carcinoma, diagnosis and treat- ¢ Potential kidney donors, coun- e Liver enzymes, abnormal levels, METABOLIC ment. 89(8):60 seling family members. 89(3):73 evaluation and significance in ¢ Lactose intolerance, clinical NERVOUS OTORHINOLARYNGOLOGIC DiS- asymptomatic patients. 89(4):137* symptoms, diagnosis, and avoid- e Neuroleptic malignant syn- EASES © Office laboratories—registering ance of symptoms. 89(8):175* drome, recognition and treatment. © Maxillary sinus hypoplasia mis- with the Health Care Financing Ad- MIGRAINE: See Headache 89(5):175* diagnosed as chronic sinusitis, use ministration. (ED) 89(2):15 MILITARY MEDICINE NEUROLOGIC MANIFESTATIONS of computed he in diag- ¢ Proposed regulations on office e Field training for medical pre- e Alzheimer’s disease, clues to its nosis. (CR) 89(4):18! laboratories—practicing primary paredness during combat, A+ to cause. 89(4):231* ¢ Motion sickness, theory on care physicians won’t be included our armed forces. (ED) 89(5):15 ¢ Cranial neuropathy, symptom of causes, drugs for prophylaxis in rule making. (ED) 89(3):13 e US Navy’s amazing hospital type Il diabetes, report of case. and/or treatment and their side ef- ¢ Relevant assays in diagnosis of ships. (ED) 89(6):15 (CR) 89(8):161 fects. 89(6):139* rheumatic diseases. 89(2):93* MOTION SICKNESS ¢ Deficits, preceded by migraine OXYGEN ¢ Routine Pap smear screening ¢ Cause, drugs for prophylaxis in young woman, link to stroke. ¢ Hyperbaric, for smoke inhalation for all women. (PH) 89(1):27 and/or treatment and their side ef- (CR) 89(7):87 injuries. (VP) 89(1):221 © Serologic tests in diagnosis of fects. 89(6):139* * Diabetic amyotrophy, report of connective tissue disease. 89(4): MOUTH DISEASES case in which patient had no pain. PAIN ¢ Bruxism, causes, guidelines for (CR) 89(3):90 ¢ Eye with headache, presenting ¢ Specimen collection and trans- treatment. 89(8):167* ¢ Febrile convulsions, current symptom of diabetes. (CR) 89(8): port for diagnosis of anaerobic in- MUSCULOSKELET, DISORDERS management recommendations. 161 fections. 89(8):227 ¢ Acute monarticular arthritis, 89(5):217* ¢ In elderly, stepwise prescription © Synovial fluid and biood analysis need for rapid diagnosis and treat- e Headache: See Headache of analgesics and adjuvant agents for diagnosis of monarticular ment. 89(7):79* ¢ Multiple sclerosis, evaluation us- for pain control. 89(4):217* arthritis. 89(7):82 e Ankle sprains, diagnosis and ing magnetic resonance imaging PANCREATIC DISEASE LANGUAGE treatment, rehabilitation. 89(1):251* to rule out other diagnoses. 89(8): * Gallstone pancreatitis, choosing ¢ Adverbial mischief with Dr Tom ¢ Charcot’s disease in diabetic and timing treatment, with repre- Swift. (PH) 89(4):20 patients, diagnostic approach. * Neurogenic oropharyngeal dys- sentative case reports. 89(2): 123* LIVER DISEASES 89(4):163* phagia, evaluation and manage- e Pseudocysts, operative and ¢ Abnormal liver enzyme levels, ¢ Foot problems, identification ment. 89(5):203* nonoperative treatment methods evaluation and significance in and management. 89(5):183* ¢ Neuropathic arthropathy, or and success rates. 89(4):199"* asymptomatic patients. 89(4):137* ¢ Growth and development ab- Charcot’s disease, diagnostic ap- PATIENT EDUCATION ¢ Cirrhosis, cause of gynecomas- normalities in patient with juvenile proach. 89(4):163* e Chlamydial infections. (PN) tia, report of successful treatment hypothyroidism. (CR) 89(2):59 * Neuropathy, diabetic, effect on 89(7): 94, 97 with tamoxifen. (CR) 89(2):191 e Lower limb problems in diabetic lower limbs. 89(8):237* ¢ Component of therapy for Ray- ¢ Cirrhosis complicated by bleed- patients, causes, treatment, and NUTRITION naud’s syndrome. 89(4):174 ing esophagogastric varices, treat- prevention. 89(8):237* ¢ Dietary control in type II dia- ¢ Congestive heart failure. (PN) ment methods. 89(6):147* ee (PN) 89(4):278, betes. 89(4):66 89(6):212, 215 1 continued VOL 89/NO 8/JUNE 1991/POSTGRADUATE MEDICINE TO VOLUME 89 CONTINUED ¢ Heimlich maneuver for choking. complicate management. (CR) * Magnetic resonance imaging in * Coexisting chlamydial and gono- (PN) 89(3):100, 103 89(5):61 diagnosis of muitiple sclerosis. coccal infections, detection and © Hypertension. (PN) 89(8):278 89(8):187* treatment to avoid serious compli- e Infectious mononucleosis. (PN) ® Medical care in Peru, stark con- ¢ Ventilation-perfusion lung scan- cations. 89(7):56* 89(5):248, 251 trast to US system. (MEM) 89(8): ning in diagnosis of pulmonary ¢ Syphilis, recent upswing in oc- ee. (PN) 89(4):278, 249 embolism. 89(8):195 currence, diagnosis and treatment. 1 PREGNANCY: See Obstetrics/Gy- © X-ray studies of joints to detect 89(1):193* e Preventing delay in seeking care necology monarthritis. 89(7):82 ¢ Viral diseases in women, latest for cancer symptoms. 89(4):151* MEDICINE RAYNAUD'S methods of diagnosis, manage- ¢ Recommendations for interna- ¢ Guidelines for prevention of * Diagnosis and treatment. 89(4): ment, and prevention. 89(2):133* tional travel, with information workplace exposure to human im- 171° SKIN DISEASES about food and beverage con- munodeficiency virus infection. RECTAL DISEASES e Acne A treatment guide- sumption, vaccinations, and pre- 89(3):33 e Hemorrhoids, internal and exter- lines. 8 vention of insect-borne disease. ¢ Helping reduce adolescent risk nal, treatment choices. 89(1):149* ° Bacteria infections in children, 89(8):149 for AIDS. 89(3):52 REHABILITATION examples with appropriate treat- ¢ Rheumatoid arthritis. (PN) 89(2): e Reducing incidence of non- ¢ Methods to reduce anxiety and ments. 89(4):109* 228, 231 steroidal anti-inflammatory drug depression in patients after acute ° ye | ace identifica- ¢ Smokeless tobacco. (PN) 89(1): (NSAID)—induced ulceration. myocardial infarction. 89(3):85 tion. 89(2):15 268, 273 © Of sprained ankle. 89(1):254 © Butterfly im and malar flush, e Using portable blood glucose PSY PSY Dis- RESEARCH ten disorders that may cause such meters for effective diabetes con- ORDERS ° — advances in diabetes. changes and their clinical charac- trol. 89(4):81 e Alcoholism, identifying alcoholic 89(6):45 teristics. 89(1):225* PATIENTS patients, particularly the elderly, DISEASES ¢ Changes associated with con- e Considering the concept of overview of treatment principles ¢ Bronchial asthma, effects on nective tissue disease. 89(4):254 “greater good” and the “lesser 89(5):139"* and of pregnancy. 89(1):125* ¢ Dermatoses, allergic and reac- bad” it may imply. (MEM) 89(1):155 e Anorexia or bulimia, under- © Smoke inhalation injuries, hyper- tive, identification and treatment. Why they delay seeking care for standing their development and in- —_ oxygen therapy. (VP) 89(1): 89(8):75* cancer symptoms. 89(4):151* terrupting the patterns. 89(4):209* ¢ Sun-related, long-term effects, PEDIATRICS * Depression after acute myocar- ¢ Spontaneous pneumomedias- recommendations for protection. © Acne vulgaris, treatment guide- dial infarction, risk factors and tinum, include in differential diag- 89(8):51* lines. 89(8):40° en intervention. 89(3): nosis of sore throat and neck pain. SOCIAL e Adolescents, helping them re- (CR) 89(1):257 ¢ Poverty and state of medical duce risk of AIDS. 89(3):49* ¢ Psychiatric factors in chronic fa- ¢ Mechanical ventilation, weaning care in Peru. (MEM) 89(8):249 e Anorexia or bulimia, under- tigue syndrome. 89(2):50 patients, management strategies SPORTS standing their development and in- ¢ Psychosocial effects for poten- to achieve a successful outcome. e Ankle sprains, diagnosis and terrupting the patterns. 89(4):209* tial and actual kidney donors. 89(1):171* treatment, rehabilitation. 89(1):251* ¢ Bed-wetting, current manage- 89(3):76 RESUSCITATION e Eye protection for athletes, gen- ment options. 89(2):63* ¢ Stress, role in physical iliness, e Emergency in children, role of eral recommendations. 89(5):121 ¢ Bruxism in children, causes, what research has discovered intraosseous infusion. 89(4):129* ¢ Stress fractures in athletes, in- oo for treatment. 89(8):167* about its effects. 89(1):159* ¢ Heimlich maneuver for choking. creasing incidence, need for thor- Emergency resuscitation, roie of ¢ Grief, differentiated from de- (PN) 89(3):100, 103 ough medical workup and modifi- pir ere. mm infusion. 89(4):129* pression, an approach to counsel- © initial steps for success, with a cation of training regimen. 89(6): ¢ Febrile convulsions, current rec- a support for patients. 89(8): helpful mnemonic. 89(1):117* ommendations for management. RHEUMATIC DISEASES e Use of substances to increase 89(5):217°* PUBLIC HEALTH ¢ Acute monarticular arthritis, muscle mass and energy, what ¢ Growth and development ab- * Common “designer drugs” and need for rapid diagnosis and treat- they are and their effects. 89(2): normalities in juvenile hypothy- their effects, identification and ment. 89(7):79* 195° roidism. (CR) 89(2):59 treatment of intoxication. 89(6):67* © Connective tissue disease, cur- STRESS © Skin infections, examples with © Controlling sexually transmitted rent diagnostic criteria and role of ¢ Role of stress in physical illness, appropriate treatments. 89(4):109* viral diseases in women through serologic tests. 89(4):253* what research has discovered ¢ Traumatic vulvar hematomas, identification of infectious individu- * Gouty arthritis, guidelines for about its effects. 89(1):159* most often in adolescent or =. and patient education. 89(2): use of antihyperuricemic drugs in STROKE younger girls, evaluation and ap- 1 treatment. 89(2):111* ¢ Caused by extracranial athero- propriate treatment. 89(4):115* © Eastern Europe travel, guide- ¢ Laboratory tests in diagnosis. sclerosis and cerebrovascular dis- PHYSICIANS lines for patients. 89(4):143* 89(2):93* ease, evaluation and management, ¢ Breaking the law was a good ¢ Syphilis, recent upswing in oc- e Rheumatoid arthritis, new devel- controlling risk factors. 89(4):193* deed in this case. (MEM) 89(3):93 currence, diagnosis and treatment. opments in treatment. 89(2):75* ¢ Preceded by vascular headache, ¢ Compassionate bedside medi- 89(1):193* e Rheumatoid arthritis. (PN) 89(2): report of case in young woman. cine. (MEM) 89(2):164 PUBLISHING 228, 231 (CR) 89(7):87 ¢ Finding a personal physician for —— never pays. (ED) 89(4): a physician. (PH) —3(2):25 SCREENING ¢ Characteristics, recommenda- ¢ Focusing on outcomes, not in- PULMONARY DISEASES: See Res- ¢ For breast cancer, methods tions for photoprotection. 89(8):60, comes. (PH) 89(8):33 piratory diseases used. 89(3):55* 6 ¢ Lack of enthusiasm for medical e For coronary artery disease. SURGERY careers at junior high career day. RADIOGRAPHY 89(1):47 ¢ Breast reconstruction foilowing (PH) 89(5):20 © Chest, potential for misdiagno- © Questionnaires for identifying al- —s current options. 89(8): © Power of intuition in en sis in cases of posttraumatic aortic coholic patients. 89(5):140 ium. (PH) 89(6): 25 aneurysm. 89(6):173* © Cardiac, for valvular heart dis- ¢ Remembering to really look at RADIOLOGIC DIAGNOSIS e Febrile, current recommenda- ease, role of echocardiography. patients not just the numbers. © Chest films signaling presence tions for management. 89(5):217* 89(6):123 (MEM) 89(7):69 of lung cancer. 89(4):101 SEX BEHAVIOR ¢ Cardiac transplantation, selec- ¢ Chest radiograph to diagnose e Adolescents and AIDS, educa- tion criteria and posttransplanta- * From neuroleptic therapy—neu- — syndrome. (CR) 89(4): tion to reduce risk. 89(3):51 tion management. 89(6):113 roleptic malignant syndrome— SEXUAL ¢ For hemorrhoids when nonoper- recognition and treatment. 89(5): ¢ Computed tomography to dis- . — tracing the cause. ative methods fail. 89(1):149 175* tinguish maxillary sinus hypoplasia 89(5):67 e¢ Resection for small-cell and * Salicylate from enteric-coated from chronic sinusitis. (CR) 89(4): SEXUALLY TRANSMITTED DiSs- non-small-cell carcinomas of the aspirin, delayed absorption may 189 EASES lung. 89(4):101 * Chlamydial infections. (PN) 89(7): ransplantation, kidney, ser 94, 97 ing potential donors. 89(3):73 continued VOL 89/NO 8/JUNE 1991/POSTGRADUATE MEDICINE ont _ INDEX TO VOLUME 89 CONTINUED TOPICAL SOLUTION minoxidil 24W W INDICATAINDO UNSASGE Male pattern baldness (alopecia androgenetica) of the vertex of the scalp. No effect has been seen on frontal baldness. At least four months of treatment are generally required before evidence of hair growth can be expected; further growth continues TECHNOLOGY, MEDICAL TRAVEL MEDICINE throouneg yhear . The new growth is not permanent; cessofa tretatmeint owilnl l ead © Portable blood glucose meters, ¢ Eastern Europe travel, _guide- to its loss in a few months. teaching patients how to correctly lines for patients. 89(4):143 CONTRAINDICATIONS — diabetes. 89(4):75* ¢ International travel, health risks, a to minoxidil, propylene glycol or ethanol. with information about immuniza- D° rainage of pancreatic pseudo- tion, food and beverage consump- I1. ne froma! sapBe fore starting treatment, make sure that the patient has a percutaneously or en- Bort):a1 4n7d prophylactic treatment. Saye doscopically. 89(4):203 ¢ Hyperbaric oxygen for smoke ° Motion sickness, drugs for pro- extensive use of topical minoxidil has not inhalation injuries. (VP) 89(1):221 phylaxis and/or treatment, side ef- e Intraosseous infusion, role in fects. 89(6):139* pay resuscitation in chil- TuMmoRs: See Neoplasms dren. 89(4' r © Mechanical ventilation, manage- ULCER (Review the package insert for LONITEN® Tablets for details): ment strategies to achieve suc- © Foot, in patients with diabetes, ——psearlitc aarnddi awla teerff urseitoenn,ti opne,r icgardeitins, etrampaaonnlda dlioec zal eeddem a cessful weaning. 89(1):171* causes, prevention and treatment. —tac © Nutrition support of a ill 89(8):238 rr ae laa patients, guidelines. 89(5):193 ¢ Peptic, association with use of Patwiith eundenrlyting she art disease, including coronary artery disease and con- © Sliding-scale insulin therapy, nonsteroidal anti-inflammatory gestheairtv faielur e, would be at particular risk of these potential effects. Additive proposed — and potential drugs. 89(7):33* effects could also emerge in patients being treated for hypertension problems.8 ¢ Peptic, current management Potential patients should have a history and physical, should be adviosf epodte n- THYROID A - 2-8 ae future prospects. 89(4): tial risks and a risk/benedefciistio n should be made. Heart patisheounld tresali ze © Hypothyroidism, juvenile, growth that adverse effects may be serious. Alert patients to the possibilityo f and development abnormalities. tachycardianad fluid retention, and monitor for increaheasrte rdat e, weight gain or (CR) 89(2):59 VACCINATION: See Immunization other systemic effects. TOBACCO VASCULAR See Cardio- PRECAUTIONS © Smokeless. (PN) 89(1):268, 273 vascular diseases General Precautions: Monitor patients one month after starting ROGAINE and at TRANSPLANTATION VENEREAL See Sexual- least every six months afterward. Discontinue ROGAINE if systemic efiects occur. © Cardiac, selection criteria and ly transmitted diseases The alcoho! base will burn and irritate the eye. If ROGAINE reaches sensitivsuer - posttransplantation management. VIRAL DISEASES = eye, abraded skin and mucous membranes) bathe with copious cool 89(6):113 ¢ Human immunodeficiency virus e Kidney, preparing potential infection in healthcare workers, igp ce pane pment erga meee ae teeth ge | reti- donors, counseling family mem- what is risk and what to do before noids and petroolr aagtentus mth at enhance percutaneous absorption. ROGAINEi s bers. 89(3):73* and after exposure. 89(3):30* for topiucsea olnl y. Each mL contains 20 mg minoxidil and accidental ingestion TRAUMA ¢ Human papillomavirus, sexually could cause adverse systemic effects. e Ankle sprains, diagnosis and transmitted cause of genital warts, Decreased integrity of the epidermal barrier caused by inflammation or disease of treatment, rehabilitation. 89(1):251* latest information on diagnosis the skin, eg, excoriations, psorori seaverse isunsbur n, may increase minoxidil e Eye injuries, causes and preven- and therapy. 89(2):137 absorption tion. 89(5):121* © Infectious mononucleosis. (PN) Patient Information: A patient information leaflet is included with each package and e Fails in elderly, determining 89(5):248, 251 in the full product information. cause, approach to prevention. © Sexually transmitted, in women, Drug Interactions: No drug interactions are known. Theoretically, absorbed minoxidil 89(1):139* latest methods of diagnosis, man- may potentiate orthostatic hypotension ii n patients taking guanethidine. ¢ Nonobstetric vulvar hematomas, ——. and prevention. 89(2): Carc and |i i of Fertility: No carcinogenicity was evaluation and appropriate treat- mfcaorluenead s emwidic teeh. toInp ircatasl, aptephleircea twiaosn .a O draols ea-ddmeipneinstdreantti onr edmuacyt ieobne ains secoocnicaetp etdi owni tnhrao taden.u line- si n m¢ enPtr.e v8e9n(t4i)n:g1 15p*o ol drownings with V© ITNAiaMcIiNnS, no need to self-medicate Pregnancy Category C: ROGAINE should not be used by pregnant women. a Safety cover. (ED) 89(8):19 for control of high cholesterol. (CT) ¢ Sunburn, long-term effects of 89(4):262 Nursing Mothers: ROGAINE should not be administered. sun exposure, recommendations Pediatric Use: Satety and effectiveness have not been established under age 18. for protection. 89(8):51* WOUNDS AND INJURIES: See Trau- ADVERSE REACTIONS ma ROGAINE was used by 3510 patients in placebo-controlled trials. Except for der- matologic events, no individual reaorc retactiionso grnoup ed by body systems appeared to be increased in the minoxidil-treated patients. (bronchitis, upper respiratory ——. sinusitis) 5.95%; Derma- tologic (irritant or allergic contact dermatitis) 5.27%; Gastrointestinal (diarrhea, nausea, a 3.42%; Neurology( t ate dizziness, faintness, light-headedness)2 .56%; Musculoskeletal (fractures. back pain, tendinitis) 2.17%: Cardiovascular aon chest pain, blood pressure increases/decreases, palpitation, pulse rate increases/decreases) 1.28%; Allergy wneunane allergic Sreeancstieosns ,( choinvjeusn,c tiavlilteirsg,i c earhri niitnifse,c tfiaocnisa,l svewretlilgion)g 0a.n9d4 %s; ensitivit1y.)0 3%; Special AUTHORS (edema. weight gain) 0.60%; Urinary Tract (urinary tract infections, renal calculi, urethritis) 0.46%; Genital Tract (prostatitis. epididymitis) 0.46%; Psychiatric (anxiety, depression, fatigue) 0.28%; Hematology (lymphadenopathy, thrombo- ——— 0.23%; Endocrine 0.09%. ients have been followed for up to 5 years and there has been no change in ADAMS DB BAUM JJ matiemeonaluataaaaa’ . Additional events reposirncte emardke t- See AndersonM C Outcomes, not incomes. (PH) ing include: eczema, hypertrichosis, local erythema, pruritus, dry skin/scalp flaking, ADLER AG 89(8):33 sexual d) , visual disturbances inchiding decreased visual acuity, exacer- See ZiringD J BELL DSH bation ofh air loss, alopecia. ANDERSONK A Lower limb in diabetic DOSAGE AND ADMINISTRATION A practical guideto nitrate use. patients: What are the causes? Haaind rsca lp should be dry before application. 1 mL should be applied to the total 89(1):67 What are the remedies? 89(8):237 affearecas ttwiece ddai ly. Total daily dose should not exceed 2 mL. Ift he fingertips ANDERSONM C BISHOP M are used to facilitate drug application, wash the hands afterwards. Pancreatic pseudocysts: When See Messmore HL HOW SUPPLIED to drain, when to wait. 89(4):199 BLAKE RL Jr 60 mL bottle with multiple applicators NDC 0009-3367-05 See Pierce RP Caution: Federal law prohibits dispensing without a prescription. BARSKY HE BLANKENHORN DH Asthma and ncy: A chal- Treating serum I abnormali- a for everyone concerned. ties in high-priority patients. 89(1):425 89(1):81 | continued : DERMATOLOGY lidhied DIVISION The Upjohn Company Kalamazoo, Mi 49001 USA © 1991 The Upjohn Company April 1991 USJ 4647.00 VOL 89/NO 8/JUNE 1991/POSTGRADUATE MEDICINE RE EN RRC TT INDEX TO VOLUME 89 CONTINUED BOZZOLA FG DeWITT DE GIBBONS GW rations? 89(4):52; (correction) See Gorelick PB Dyspareunia: Tracing the cause. See Giurini JM 19(6):31 BRADLEY JG 89(5):67 GILBERT G Nonprescription drugs and hy- DICKERMAN J Peptic ulcer disease: How to Options for pai local anes- pertension: Which ones affect Ophthaimoplegia with headache: treat it now. 89(4):91 thesia. 89(3):71 blood pressure? 89(6):195 Be aware of diabetes. (CR) 89(8): GIURINI JM HORNER J BRNA TG Jr 161 Charcot’s disease in diabetic pa- Managing dysphagia: Special Agranulocytosis from antiar- tients: Correct diagnosis can pre- problems in patients with neuro- : What to watch The rash and the malar vent progressive deformity. 89(4): logic disease. 89(5):203 for when a medication is first pre- flush: What diseases do these 163 HOWARD RB scribed. 89(1):181 signs reflect? 89(1):225 GOLDBERG RJ Dr Tom Swift returns, unexpect- BRONSON D DRIGGERS DA See Taffet SL edly. (PH) 89(4):20 th pal Emergency resuscitation in chil- GOLDBERG SH HUDSON NP BROWN RG dren: The role of intraosseous in- Blistering diseases: Diagnostic When to suspect connective tis- Determining the cause of ane- fusion. 89(4):129 help for primary care physicians. sue disease. 89(4):253 mia: General approach, with em- DUCKWORTH we 89(2):159 HUNT S phasis on mic ic hypochromic intensive management of type II GOLLER V =o mn umbers. (MEM) 88(7):69 anemias. -a pc e diabetes. 89(4):65 See Driggers DA GONIK B See oKa n MG mias. 89(8):125 EDES TE See Peaceman AM BUCKNER ET Nutrition support of critically ill GORELICKP B ITSKOVITZ HD De you have patients with patients: Guidelines for optimal Alzheimer’s disease: Clues to the Alpha, blockers: Safe, effective anorexia or inderstand- management. 89(5):193 cause. 89(4):231 treatment for hypertension. ing is the first step in helping. EDWARDS NL GORRELLR L 89(8):89 89(4):209 to lower uric acid levels: Niacin caution. (CT) 89(4):262 BULL DA How to avoid misuse in gouty GRAUER K JACOBS MB See Valente JF arthritis. 89(2):111) See Rey AM G ja: A bothersome but BURRITT MF EDWARDS WD GRIFFIN GC readily treatable problem. (CR) Portable biood glucose meters: See O’Keefe JH Jr Don’t iarize—even yourself! 89(2):191 Teaching patients how to correctly EGBERT AM (ED) 89(4):15 JACQUES PF monitor diabetes. 89(4):75 Help for the : Safe ‘HCFA police,’ lab ba prison, See Petty SM = of drugs to relieve pain. 89(4): and you! (ED) 89(1): JERKINS GR 1 aaa says ‘keep ua (ED) 89(3): See Rosenfeld J SeeG iberG ELSASSER GN JEWELL GS See Kavan MG | put a ‘fence’ over my pool. (ED) See Driggers DA Pm on VL ELY Jw 89(8):19 JOHNSON R CHRISTENA G aa care of Kathy. (PH) 89(3): Oregon’s healthcare rationing See Driggers DA Smokeless tobacco. (PN) 89(1): 1 list: Where would you draw the JONES K 268, 273 EVANKO D line? (ED) 88(7):15 See Sallis RE CHRISTMAN JE ‘Designer drugs’: Treating the Our navy’s amazing hospital See Gianini GD damage caused by basement ships. (ED) 89(6):15 KAHN JK CHRZAN JS chemists. 89(6):67 peu p to lat tests—or else! Advances in noninvasive detec- See Giurini JM (ED) 89(2):15 tion of CAD. 89(5):149 COCCHIARA JL FARBER AS Today’s M*A*S*H: As high tech as Congestive heart failure. (PN) Hemorrhoids: A practical ap- Preventing eye injuries: What to Patriot missiles. (ED) 89(5):15 89(6):212, 215 proach to an aggravating problem. tell patients. 89(5):121 GUMS JG Progressive congestive heart 89(1):149 FELEKE G See Rey AM failure: Ways to approach office COLLETTE RP Anaerobic i : The basics management. 89(6):102 See Vinson RP - primary care physicians. 89(8): HABERSHAW GM KATZ CM CORMAN LC 1 See Giurini JM How efficient is sliding-scale in- Rheumatoid arthritis. (PN) 89(2): FENNERTY BP HADDAD og sulin therapy? Problems with a 228, 231 See Valente JF Chilaiditi’s syndrome: A diagnos- ‘cookbook’ approach in hospital- arthritis: New devel- FILLIPO BH tic oye ot( CR) 89(4):249 ized patients. 89(5):46 opments in treatment. 89(2):75 What to do when results of a HAINESJ D KAVAN MG COSTA AJ Western it test are i i- meg ‘mononucleosis. (PN) Depression after acute myocar- Preventing falls in your elderly nate. 89(3):39 89(5):248 dial infarction: The role of primary patients. 89(1):139 FINCHER RME Old Jess. (MEM) 89(2):164 care physicians in rehabilitation. CROUCH TT See Kilpatrick SE HAMBLIN JE 89(3):83 See O’Dell ML FISHMAN SM See Schifeling DJ KENT JR CROW HE For the greater good? (MEM) HANSON E See Moeser PJ How to help patients understand 89(1):155 See Burritt MF KILPATRICK SE and conquer grief: Avoiding de- HANSON MA Musculoskeletal abnormalities pression in the midst of sadness. Drug fever: Remember to consid- in a patient with juvenile hypo- 89(8):117 er it in diagnosis. 89(5):167 thyroidism. (CR) 89(2):59 CURRIE PJ See Smith CB HARRISON RV KING PD Valvular heart disease: A cor- FORLENZA S See Ruckenstein MJ Abnormal liver enzyme levels: rectable cause of congestive heart See Feleke G HART GB Evaluation in asymptomatic pa- failure. 89(6):123 FRENKELM A See Meyer GW tients. 89(4):137 Spontaneous pneumomedias- HEIMLICH HJ KRESSNER MS DAVIS JM tinum: An unusual cause of a sore The Heimlich maneuver for See Taffet SL Midnight musings of the :mid- throat. (CR) 89(1):257 ing. (PN) 89(3):100, 103 KROENKE K brain. (PH) 89(6):25 HENRY K Chronic fatigue syndrome: Is it Pap tests needed for women of GARBER JG HIV infection in healthcare work- real? 89(2):44 all ages. (PH) 89(1):27 Osteoporosis. (PN) 89(4):278, 281 ers: How great is the risk? What KWAN L DENNY sc GAZEWOOD J can be done before and after ex- See Marcus S See Lange WR See Pierce RP posure? 89(3):30 SDeePA OyLoIu S a Mr eal doctor?’ (PH) 89(5): TGrI ANINI GtiDc vulvar h + HSeOeD ISB laHnNk enhorn DH LSeAeC LHEa dJd ad CJ Assessing and treating nonobstet- HOLLANDER P LANGE WR ame in my bedroom. (PH) 88(7): ric patients. 89(4):115 Premixed insulins: How do they Traveli n eastern Europe: Guide- compare with other insulin prepa- lines for patients. 89(4):143 My doctor, myself. (PH) 89(2):25 VOL 89/NO 8/JUNE 1991/POSTGRADUATE MEDICINE LAVIE CJ O’KEEFE JH Jr SALGADO ED TAYLOR MB Assessment of stable ischemic Degenerative aortic stenosis: Extracranial atherosclerosis and Treatment of acne vulgaris: heart disease: Which tests are One effect of the graying of Ameri- cerebrovascular disease: Mini- Guidelines for primary care physi- best for which patients? 89(1):44 ca. 89(2):143 mizing the risk of stroke. 89(4):193 cians. 89(8):40 See also O’Keefe JH Jr OLDENBURG WA SALLIS RE TENNER S Renovascular hypertension: Dif- Stress fractures in athletes: How See Schroth S ficulties in diagnosis and treat- to spot this underdiagnosed injury. THOMAS E ment. 89(5):93 89(6):185 See Gilbert G Complications of coexisting OPPENHEIM EB THURN J chlamydial and gonococcal in- Limo to Lima. (MEM) 89(8):249 See Rainer C See Henry K fections. 88(7):56 SCHIFELINGD J TOBIN MJ LEUNG AKC PARISER RJ Early diagnosis of breast cancer: Weaning patients from mechani- Bruxism: How to stop tooth grind- Allergic and reactive derma- eogss. screening is essential. cal ventilation: How to avoid diffi- ing and clenching. 4 167 toses: How to identify and treat '3):55 Culty. 89(1):171 convulsions: How danger- them. 89(8):75 SCHROTH S TUCKER VL ous are they? 89(5):217 PARKER LA When migraine is more than a AIDS and adolescents: : How can LIVINGSTOENH See Petty SM headache: Stroke in a young pa- you help them reduce their risk? Resuscitation: Revival should be PASSARO EP Jr tient. (CR) 88(7):87 19(3):49 the first priority. 89(1):117 See Livingston EH SCOTT TF LOVE N PEACEMAN AM Diseases that mimic multiple VALENTE JF Why patients delay seeking care Sexually transmitted viral dis- sclerosis. 89(8):187 Gallstone pancreatitis: Choosing for cancer symptoms: What you ease in women. 89(2):133 SETNESS PA and timing treatment. 89(2):123 can do about it. 89(4):151 PELTZS Chlamydial infections. (PN) 89(7): VENTURA HO LYONS LL Severe thromb i sec- See Lavie CJ See Frenkel MA ondary to wen ‘use. (CR) s VINSON RP 89(6):75 P y p Maxillary sinus hypoplasia mas- MANDELLV S PERMAN JA Lessons for the ’90s. 89(8):195 querading as chronic sinusitis. See Petty SM See Montes RG SILFVERSKIOLD JP (CR) 89(4):189 MARCUS S PETTY SM Common foot problems: Reliev- Raynaud’s syndrome: Using a Chronic posttraumatic aortic ing the pain of bunions, keratoses, WASSERSUG JD range of therapies to help patients. pseudoaneurysm: Recognition corns, and calluses. 89(5):183 Acts of kindness. (MEM) 89(3):93 89(4):171 before rupture. 89(6):173 SILVERSTEIN F A very good husband. (MEM) MARSHALL JE PETTY TL Nonsteroidal anti-inflammatory 89(6):39 Bleeding esophagogastric var- What to do when an x-ray film drugs and peptic ulcer disease: ices: Ways to treat active episodes suggests lung cancer. 89(4):101 An overview. 88(7):33 See Messmore HL and prevent recurrence. 89(6):147 PIERCE RP SKYLER JS WEINER SR Salicylate poisoning from enter- Strategies in diabetes mellitus: See Marcus S ic-coated aspirin: Delayed ab- Start of a new era. 89(6):45 WELBORN JL sorption may complicate manage- SMITH CB A three-point approach to ane- ment. (CR) 89(5):61 Control of hypertensive emer- mia. 89(2):179 PRAWER SE gencies. 89(5):111 WELLS RG a celiac axis a skin diseases. 89(8): SMITH CJ Managing miscarriage: The need syndrome? — 239 1 The courage of Grace. (MEM) for more than medical mechanics. 89(5):39 89(2):207 nace vteanoeu s Thera- RAINER C SPEES DN WILLIAMS RC Jr peutic choices for superficial and Neuroleptic malignant syndrome: Health risks of foreign travel: See Yancey WB Jr deep veins. 88(7):73 When poem 4 withdrawal is the Preparing adults for jaunts abroad. WOOLDRIDGE WE METHOD MW cause. 89(5):17: 89(8):147 Managing skin infections in chil- See Gianini GD RAPPAPORT 4 STACK PS dren. 89(4):109 MEYER GW See Valente JF Ogilvie’s syndrome: Would you Syphilis: A new visit from an old Hyperbaric oxygen therapy for REINHARDT CE recognize it? 89(5):131 enemy. 89(1):193 acute smoke inhalation injuries. See Smith CB STANLEY KL WOOLLEY BH 89(1):221 REISER AH Jr Ankle sprains are always more The latest fads to increase mus- MEYERS FJ Walking on glass. (MEM) 89(4):41 than ‘just a sprain.’ 89(1):251 cle mass and energy: A look at See Welborn JL REY AM STATE D what some athletes are using. MOESER PJ Newer antihypertensive agents. Nipple discharge in women: Is it 89(2):195 Diabetic amyotrophy without 89(5):75 cause for concern? 89(3):65 pain: A puzzling clinical picture. RILEY WB Jr STEINER JF YANCEY WB Jr 89(3):90 Breast reconstruction after mas- See Driggers DA Laboratory tests for rheumatic MONTES RG tectomy: What are today’s op- STRAUSS MB diseases. 89(2):93 Lactose intolerance: Pinpointing tions? 89(8):205 See Meyer GW YANCY CW Jr the source of nonspecific gastroin- ROBSON WLM SUTHERLAND JE Severe congestive heart failure: testinal symptoms. 89(8):175 See Leung AKC Gastroesophageal reflux dis- How successful are drug and MUNENE NE ROSENFELD J : When antacids aren’t transplant therapies? 89(6):111 The bed-wetting child: Current enough. 88(7):45 management of a frustrating prob- The link between stress and ill- ZIMMERMANBR See Lavie CJ lem. 89(2):63 ness: Do our coping methods in- See BurrittM F ROSENTHAL J fluence our health? 89(1):159 ZIMMERMANF H NESSE RE Acute monarticular arthritis: SUZUKI SM When is pulmonary artery cath- Managing abnormal vaginal Sleuthing out the cause. 88(7):79 See Marcus S eteriworzth athet riiskos? n89( 2): bleeding. 89(1):205 RUCKENSTEIN MJ SWEDBERG JA 169 NISHIMURA RA Motion sickness: Helping patients See Driggers DA ZIRING DJ See O’Keefe JH Jr tolerate the ups and downs. 89(6): Alcoholism: Are you missing the 9 TAFFET SL diagnosis? 89(5):139 RUSSIN SJ Esophageal and gastric endo- See Fillipo BH scopy in critically ill patients: RYHAL BT How can it help you? 89(4):123 Donating a kidney to a family The second-generation antihis- TALLEY JH : How primary care physi- tamines: What makes them differ- Fluoroquinolones: New miracle cians can help prepare potential ent? 89(6):87 drugs? 89(1):101 donors. 89(3):73 VOL 89/NO 8/JUNE 1991/POSTGRADUATE MEDICINE